Table 2.
Procedural Findings and Complications
| PCI group, n = 233 | |
|---|---|
| Stenting techniques for left main bifurcations (n = 187) | |
| Crossover (%) | 150 (80.2) |
| Crush (%) | 26 (13.9) |
| T stent (%) | 7 (3.7) |
| Cullotte (%) | 1 (0.5) |
| V stent (%) | 3 (1.6) |
| Stent type and number (n = 233) | |
| Sirolimus‐eluting stent | 160 (68.7) |
| Paclitaxel‐eluting stent | 58 (24.9) |
| Zotarolimus‐eluting stent | 15 (6.4) |
| No. of used stents at left main lesion | 1.09 ± 0.33 |
| Complications (n = 233) | |
| Side branch occlusion (%) | 2 (0.9) |
| No/slow reflow (%) | 3 (1.3) |
| Acute thrombosis (%) | 1 (0.4) |
| Vascular perforation (%) | 1 (0.4) |
| Acute heart failure (%) | 1 (0.4) |
| CABG group (n = 282) | |
| Procedures | |
| Off‐pump (%) | 232 (82.3) |
| On‐pump (%) | 50 (17.7) |
| CABG with other cardiac surgery (%) | 21 (7.4) |
| Left internal mammary artery (%) | 222 (78.7) |
| Complications | |
| Blood transfusion (%) | 126 (44.7) |
| Renal failure needs emergent dialysis (%) | 9 (1.1) |
| Abnormal liver enzyme (%)a | 10 (3.5) |
| Severe infection needs operation (%) | 3 (1.1) |
| Hemorrhage needs operation (%) | 2 (0.7) |
| Distal embolization (%) | 1 (0.4) |
Abbreviations: CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention.
a
Abnormal liver enzyme is defined as more than 2‐fold the upper limit of aspartate aminotransferase or alanine aminotransferase.